+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Forecast 2024-2030- Product Image
Global Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Forecast 2024-2030- Product Image
Sale

Global Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Forecast 2024-2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5715509
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gene Synthesis Market size was estimated at USD 4.24 billion in 2023, USD 4.68 billion in 2024, and is expected to grow at a CAGR of 10.82% to reach USD 8.70 billion by 2030.

The gene synthesis market comprises technologies, products, and services related to the artificial creation of DNA sequences through chemical methods in various industries such as research, medicine, agriculture, and biotechnology. Key end-users include academic institutions, pharmaceutical and biotechnology companies, government agencies, and contract research organizations (CROs). The growing prevalence of chronic conditions among the global population and rising demand for personalized medicines, along with advancements in genomics research, are driving this market. Moreover, the advantage of gene synthesis over traditional methods is fueling market growth.

However, strict regulations governing the development and commercialization of GMOs and technical challenges such as limitations in size and complexity of synthetic genes limit the growth of the gene synthesis market. Emerging technologies in gene synthesis for efficiency and accuracy and the growing utilization of gene synthesis in energy and agriculture industries are creating significant growth opportunities in the market.

Regional Insights

The gene synthesis market in the Americas is highly developing owing to the presence of a developed healthcare sector and supportive government programs, which has resulted in considerable product development and the commercialization of gene synthesis technologies in the United States and Canada. This is attributed to growing improvements in R&D facilities, available disposable income, and rapidly developing economic conditions. Moreover, federal agencies and authorities have launched several initiatives, programs, and schemes to encourage gene therapy research in the region, creating a platform for gene synthesis in the Americas.

Emerging economies such as India, China, Singapore, and Malaysia are potential markets for market expansion due to improved healthcare standards. These economies have a considerable presence of domestic manufacturers of gene synthesis, which contributes to an upsurge in the market penetration of multinational giants. The growing prevalence of chronic diseases, increasing technological advancements, and improved healthcare infrastructure are the primary reasons driving the gene synthesis market in EMEA. Governments across the region have been continuously investing in gene therapies, thereby expanding the utilization of various gene syntheses. In February 2022, the Dutch government invested USD 55.04 million to build a new national pilot factory to advance the development and manufacturing of promising cell and gene therapies. The investment by the Dutch government is expected to provide excellent opportunities for cell and gene therapy companies.

Market Trends by Segment

  • Product: Expanding usage of software that helps design synthetic genes accurately
  • Method: Rising utilization of chip-based synthesis for large-scale projects
  • Gene Type: Growing potential for express gene synthesis that provides quick access to shorter genes for time-sensitive projects
  • End-use: Increasing focus on innovative drug discovery and therapeutic development across biotechnology and pharmaceutical companies
  • Gene Type: Growing potential of express genes that are optimized for high levels of expression in specific host organisms

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Evonetix and Analog Devices Inc To Progress Revolutionary Gene Synthesis Platform

Evonetix has made significant strides in partnership with Analog Devices, Inc. to reshape their approach to synthesizing DNA. The core technology integrates Evonetix's proprietary thermal control method with Analog Devices' complementary metal-oxide-semiconductor (CMOS) capabilities. The platform's unique design and temperature precision enable the production of high-fidelity, long DNA sequences, carving a path for advancements in various fields, including pharmaceuticals, data storage, and synthetic biology.

Gyros Protein Technologies and Biotage Partner to Advance Peptide Purification Efficiency With New Automated Solution

Gyros Protein Technologies partnered with Biotage to introduce an innovative automated solution designed to enhance efficiency in the purification process. This partnership allows Gyros Protein Technologies to prowess in peptide synthesis with Biotage's expertise in purification technologies, culminating in an offering that promises to deliver unparalleled throughput, performance, and ease of use. The integration of this solution into peptide synthesis workflows presents researchers with an optimized and streamlined process, leading to higher-purity peptides and potentially accelerating the pace of research and development in the biopharmaceutical sector.

Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan

Synplogen Co. and Ginkgo Bioworks entered into a partnership to accelerate the global development of DNA manufacturing and gene therapy platform services in Japan. This partnership enables Synplogen's local market acumen with Ginkgo’s global reputation in organism engineering, potentially setting a new benchmark for innovation and efficiency. The partnership aims to tap into Japan’s technological prowess and research climate, with Synplogen leveraging Ginkgo's cutting-edge platforms to enhance the development and production of DNA-based applications.

Key Company Profiles

The report delves into recent significant developments in the Gene Synthesis Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Ansa Biotechnologies, Inc., Applied Biological Materials Inc., AstraZeneca PLC, Azenta, Inc., Barcode Biosciences Private Limited, BGI Genomics by BGI Group, BioCat GmbH by AddLife AB, Biomatik Corporation, Bioneer Corporation, Biotage AB, Biotech Desk Pvt. Ltd., Boster Biological Technology, Brooks Automation Inc., Camena Bioscience, Charles River Laboratories International, Inc., Constructive Bio Ltd, Creative Biogene, Danaher Corporation, DNA TwoPointO Inc., Elabscience Biotechnology Inc., Elegen Corp., Eurofins Scientific SE, Evonetix Ltd., GenCefe Biotech Limited, Gene Universal, Inc., General Biosystems, Inc., GenScript Biotech Corporation, Ginkgo Bioworks Holdings, Inc., Macrogen, Inc., Merck KGaA, NZYTech, Lda., OriGene Technologies, Inc., ProMab Biotechnologies, Inc., ProteoGenix SAS, QIAGEN N.V., Synbio Technologies LLC, Telesis Bio Inc., Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

This research report offers invaluable insights into various crucial aspects of the Gene Synthesis Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic conditions among the global population
5.1.1.2. Increasing genomics research activities and rising focus on personalized medicines
5.1.1.3. Growing investments by the private and public sectors in pharmaceutical research
5.1.2. Restraints
5.1.2.1. Strict regulations governing gene synthesis and high cost associated with the process
5.1.3. Opportunities
5.1.3.1. Emerging new technologies in gene synthesis
5.1.3.2. Utilization of gene synthesis in energy and agriculture industries
5.1.4. Challenges
5.1.4.1. Limitations in size and complexity of synthetic genes
5.2. Market Segmentation Analysis
5.2.1. Product: Expanding usage of software that helps design synthetic genes accurately
5.2.2. Method: Rising utilization of chip-based synthesis for large-scale projects
5.2.3. Gene Type: Growing potential for express gene synthesis that provides quick access to shorter genes for time-sensitive projects
5.2.4. End-use: Increasing focus on innovative drug discovery and therapeutic development across biotechnology and pharmaceutical companies
5.2.5. Gene Type: Growing potential of express genes that are optimized for high levels of expression in specific host organisms
5.3. Market Trend Analysis
5.3.1. Ongoing technological advancements to increase the speed of synthetic gene production coupled with a strong foothold of major players in the Americas region
5.3.2. Robust R&D activities in biotechnology and pharmaceutical sectors and the rising need for synthetic gene applications in the Asia-Pacific
5.3.3. Supportive government initiatives for genomic projects and advancing use of gene synthesis in agricultural sector in EMEA
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Gene Synthesis Market, by Product
6.1. Introduction
6.2. Hardware
6.3. Services
6.4. Software
7. Gene Synthesis Market, by Method
7.1. Introduction
7.2. Chip-Based Synthesis
7.3. PCR-Based Enzyme Synthesis
7.4. Solid-Phase Synthesis
8. Gene Synthesis Market, by Gene Type
8.1. Introduction
8.2. Complex Gene
8.3. Express Gene
8.4. Standard Gene
9. Gene Synthesis Market, by Application
9.1. Introduction
9.2. Disease Diagnosis
9.3. Gene & Cell Therapy Development
9.4. Vaccine Development
10. Gene Synthesis Market, by End-use
10.1. Introduction
10.2. Academic & Government Research Institutes
10.3. Biotechnology & Pharmaceutical Companies
10.4. Contract Research Organizations
11. Americas Gene Synthesis Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Gene Synthesis Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Gene Synthesis Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. Evonetix and Analog Devices Inc To Progress Revolutionary Gene Synthesis Platform
14.3.2. Gyros Protein Technologies and Biotage Partner to Advance Peptide Purification Efficiency With New Automated Solution
14.3.3. Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan
14.3.4. Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
14.3.5. Biotech Firm Closes GBP 5.6 million Seed Financing
14.3.6. Bruker to Buy PhenomeX For USD 108 Million
14.3.7. Series Funding to Support Expansion of DNA Synthesis Technology
14.3.8. NunaBio Raises GBP 1.9M In Seed Funding To Expand Infrastructure And Accelerate R&D
14.3.9. Elegen Launches ENFINIA DNA, Rapid Long DNA Synthesis to Power the Bioeconomy
14.3.10. Ansa Biotechnologies Announces Successful de novo Synthesis of Oligonucleotide at 1005 Bases
14.3.11. GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service
14.3.12. Evonetix Closes USD 24 million Financing
14.3.13. Gene Synthesis (End-to-End) Now In India At Barcode Biosciences
14.3.14. Eurofins Genomics Blue Heron launches IVT mRNA Synthesis Service: The Future of Gene Expression
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. GENE SYNTHESIS MARKET RESEARCH PROCESS
FIGURE 2. GENE SYNTHESIS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GENE SYNTHESIS MARKET DYNAMICS
FIGURE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
FIGURE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 16. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. GENE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GENE SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY HARDWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ANTIBODY DNA SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ANTIBODY DNA SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VIRAL DNA SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VIRAL DNA SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CHIP-BASED SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CHIP-BASED SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PCR-BASED ENZYME SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PCR-BASED ENZYME SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COMPLEX GENE, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COMPLEX GENE, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL GENE SYNTHESIS MARKET SIZE, BY EXPRESS GENE, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL GENE SYNTHESIS MARKET SIZE, BY EXPRESS GENE, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL GENE SYNTHESIS MARKET SIZE, BY STANDARD GENE, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL GENE SYNTHESIS MARKET SIZE, BY STANDARD GENE, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL GENE SYNTHESIS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL GENE SYNTHESIS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE & CELL THERAPY DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE & CELL THERAPY DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL GENE SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL GENE SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 91. CANADA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 92. CANADA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 93. CANADA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 94. CANADA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 95. CANADA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 96. CANADA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 97. CANADA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 98. CANADA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 99. CANADA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. CANADA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. CANADA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 102. CANADA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 103. MEXICO GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 104. MEXICO GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 105. MEXICO GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 106. MEXICO GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 107. MEXICO GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 108. MEXICO GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 109. MEXICO GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 110. MEXICO GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 111. MEXICO GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. MEXICO GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. MEXICO GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 114. MEXICO GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 123. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 126. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 127. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 128. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 132. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 136. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 140. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 142. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 143. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 146. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 147. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 148. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 149. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 150. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 151. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 154. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 155. CHINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 156. CHINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 157. CHINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 158. CHINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 159. CHINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 160. CHINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 161. CHINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 162. CHINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 163. CHINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. CHINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. CHINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 166. CHINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 167. INDIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 168. INDIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 169. INDIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 170. INDIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 171. INDIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 172. INDIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 173. INDIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 174. INDIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 175. INDIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. INDIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. INDIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 178. INDIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 179. INDONESIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 180. INDONESIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 181. INDONESIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 182. INDONESIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 183. INDONESIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 184. INDONESIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 185. INDONESIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 186. INDONESIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 187. INDONESIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. INDONESIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. INDONESIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 190. INDONESIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 191. JAPAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 192. JAPAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 193. JAPAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 194. JAPAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 195. JAPAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 196. JAPAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 197. JAPAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 198. JAPAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 199. JAPAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. JAPAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. JAPAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 202. JAPAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 203. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 206. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 207. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 208. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 209. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 210. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 211. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 214. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 215. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 216. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 217. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 218. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 219. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 220. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 221. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 222. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 223. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 226. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 227. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 228. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 229. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 230. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 231. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 232. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 233. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 234. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 235. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 238. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 239. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 240. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 241. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 242. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 243. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 244. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 245. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 246. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 247. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 250. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 251. TAIWAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. TAIWAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. TAIWAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 254. TAIWAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 255. TAIWAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 256. TAIWAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 257. TAIWAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 258. TAIWAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 259. TAIWAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. TAIWAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. TAIWAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 262. TAIWAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 263. THAILAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 264. THAILAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 265. THAILAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 266. THAILAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 267. THAILAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 268. THAILAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 269. THAILAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 270. THAILAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 271. THAILAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. THAILAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. THAILAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 274. THAILAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 275. VIETNAM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 276. VIETNAM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 277. VIETNAM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 278. VIETNAM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 279. VIETNAM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 280. VIETNAM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 281. VIETNAM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 282. VIETNAM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 283. VIETNAM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. VIETNAM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. VIETNAM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 286. VIETNAM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 301. DENMARK GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 302. DENMARK GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 303. DENMARK GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 304. DENMARK GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 305. DENMARK GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 306. DENMARK GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 307. DENMARK GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 308. DENMARK GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 309. DENMARK GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 310. DENMARK GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 311. DENMARK GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 312. DENMARK GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 313. EGYPT GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 314. EGYPT GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 315. EGYPT GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 316. EGYPT GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 317. EGYPT GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 318. EGYPT GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 319. EGYPT GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 320. EGYPT GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 321. EGYPT GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 322. EGYPT GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 323. EGYPT GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 324. EGYPT GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 325. FINLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 326. FINLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 327. FINLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 328. FINLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 329. FINLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 330. FINLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 331. FINLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 332. FINLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 333. FINLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 334. FINLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 335. FINLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 336. FINLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 337. FRANCE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 338. FRANCE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 339. FRANCE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 340. FRANCE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 341. FRANCE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 342. FRANCE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 343. FRANCE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 344. FRANCE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 345. FRANCE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 346. FRANCE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 347. FRANCE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 348. FRANCE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 349. GERMANY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 350. GERMANY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 351. GERMANY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 352. GERMANY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 353. GERMANY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 354. GERMANY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 355. GERMANY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 356. GERMANY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 357. GERMANY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 358. GERMANY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 359. GERMANY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 360. GERMANY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 361. ISRAEL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 362. ISRAEL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 363. ISRAEL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 364. ISRAEL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 365. ISRAEL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 366. ISRAEL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 367. ISRAEL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2023 (USD MILLION)
TABLE 368. ISRAEL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2024-2030 (USD MILLION)
TABLE 369. ISRAEL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 370. ISRAEL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 371. ISRAEL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 372. ISRAEL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 373. ITALY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 374. ITALY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 375. ITALY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
TABLE 376. ITALY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
TABLE 377. ITALY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 378. ITALY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2

Companies Mentioned

  • Agilent Technologies, Inc.
  • Ansa Biotechnologies, Inc.
  • Applied Biological Materials Inc.
  • AstraZeneca PLC
  • Azenta, Inc.
  • Barcode Biosciences Private Limited
  • BGI Genomics by BGI Group
  • BioCat GmbH by AddLife AB
  • Biomatik Corporation
  • Bioneer Corporation
  • Biotage AB
  • Biotech Desk Pvt. Ltd.
  • Boster Biological Technology
  • Brooks Automation Inc.
  • Camena Bioscience
  • Charles River Laboratories International, Inc.
  • Constructive Bio Ltd
  • Creative Biogene
  • Danaher Corporation
  • DNA TwoPointO Inc.
  • Elabscience Biotechnology Inc.
  • Elegen Corp.
  • Eurofins Scientific SE
  • Evonetix Ltd.
  • GenCefe Biotech Limited
  • Gene Universal, Inc.
  • General Biosystems, Inc.
  • GenScript Biotech Corporation
  • Ginkgo Bioworks Holdings, Inc.
  • Macrogen, Inc.
  • Merck KGaA
  • NZYTech, Lda.
  • OriGene Technologies, Inc.
  • ProMab Biotechnologies, Inc.
  • ProteoGenix SAS
  • QIAGEN N.V.
  • Synbio Technologies LLC
  • Telesis Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.68 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.7 Billion
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned40

Related Topics

Related Reports

Gene Synthesis (Research Use) Market Size, Share & Trends Analysis Report By Method (Solid-phase, Chip-based), By Research Phase (Pre-clinical, Clinical), By Application, By Service, By End-use, And Segment Forecasts, 2023 - 2030 - Product Image

Gene Synthesis (Research Use) Market Size, Share & Trends Analysis Report By Method (Solid-phase, Chip-based), By Research Phase (Pre-clinical, Clinical), By Application, By Service, By End-use, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • Global
From
Global Gene Cloning Services Market by Service (Custom Cloning Service, Gene Synthesis Service, Molecular Biology Service), Application (Gene Expression, Gene Synthesis, Gene Therapy), End User - Forecast 2024-2030 - Product Image

Global Gene Cloning Services Market by Service (Custom Cloning Service, Gene Synthesis Service, Molecular Biology Service), Application (Gene Expression, Gene Synthesis, Gene Therapy), End User - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Gene Synthesis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - Product Image

Gene Synthesis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030

  • Report
  • 220 Pages
  • Global
Gene Synthesis Market Global Market Report 2024 - Product Image

Gene Synthesis Market Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Gene Synthesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Gene Synthesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 190 Pages
  • Global
From

About the Gene Synthesis Market

Gene Synthesis is a technology used in genomics to create custom DNA sequences. It involves synthesizing a gene from its component nucleotides, which are then assembled into a single strand of DNA. The technology is used in a variety of applications, including gene therapy, drug discovery, and agricultural biotechnology. It is also used to create custom DNA libraries for research and development. Gene Synthesis is a rapidly growing market, driven by advances in sequencing technology and the increasing demand for custom DNA sequences. The technology is used in a variety of industries, including pharmaceuticals, biotechnology, and agriculture. It is also used in academic research and in the development of new diagnostic tests. Companies in the Gene Synthesis market include GenScript, DNA2.0, Twist Bioscience, Eurofins Genomics, and Genewiz. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.